SEATTLE, March 16, 2021, (MEDGADGET) — Absorbable nasal implants are used in the treatment of nasal blockage or obstructions by better breathing and sleep to the patient which can be caused by septal deviation, enlarged turbinate’s, and weakened upper and/or lower lateral nasal wall cartilage. Symptoms of nasal obstruction are stuffiness, congestion or an inability to breathe through one or both nostrils. The nasal valve collapse contributes as much as 80% of the total airway resistance. Nearly 3 million Americans visit a physician for nasal obstruction and about 1 million procedures are performed to alleviate the symptoms.
Note: *The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/5
This is a severe condition and has a limited number of treatment options are available in the market. are Invasive are only available and the permanent solution is to undergo nasal valve surgery which requires extensive skills and training by the ENT specialist or facial plastic surgeons.
Alternate Treatment Options for Nasal Valve Collapse
Nasal valve dilators are available in two options – one that can be worn internally and others that are stuck externally (Breathe Right strips). Another option is rhinoplasty with or without graft to repair the nasal valve collapse.
This condition is often undertreated and under-diagnosed because of low patient awareness. An absorbable implant is a non-invasive technology to support the nasal cartilage and improve breathing. These implants are an important development for nasal obstruction patients where a standard treatment procedure for septum and turbinates are not enough. The implants are usually preferred for patients who have undergone a rhinoplasty since there is a likelihood of an extremely narrow-looking nose.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://bit.ly/3vtaeNp
Latera is the widely known Brand
There are two brands available in the global absorbable nasal implants market. These are Latera and Inex. Latera absorbable nasal implant from Spirox Inc. received the FDA approval recently in 2016. Whereas the INEX absorbable nasal implant approved by the U.S. FDA in 2015. INEX absorbable nasal implant supports septal cartilage whereas the LAtera supports upper and lower lateral nasal cartilage.
Latera is made up of copolymer, which gets absorbed in the body over approximately 18 months. The product includes a delivery device and an implant positioning guide in the accessories. The single-use delivery device is composed of a handle body, a deployment plunger and pushrod, and a 16-gauge delivery cannula with a depth marker and protective cover.
Spirox, Inc. recently announced the positive outcomes from a multi-center study of Latera absorbable nasal implant. In this study, LATERA showed significant quality-of-life improvement through one year, using the NOSE score, for nasal obstruction patients with lateral cartilage weakness resulting in nasal valve collapse. Improvements identified in the study included less nasal blockage or obstruction, less trouble breathing through the nose while at rest or during exercise, and less trouble sleeping. On the other hand, the risks associated such as mild bruising and inflammation, mild pain or irritation, discomfort, infection and reaction to the material are expected to hamper the market growth.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/absorbable-nasal-implant-devices-market-5
- Increasing clinical tests of trademarked products by key players is expected to drive the growth of the market during the forecast period. In June 2019, Stryker Corporation announced that 33,000 patients were treated with the company’s LATERA absorbable nasal implant device. The device is used to support the lateral nasal cartilage and address the symptoms of NVC, which help the patients to breathe better.
- Key players are involved in various business strategies such as product launch to gain a competitive edge in the market. In April 2018, Intersect ENT announced the launch of its SINUVA sinus implant, which is a novel in-office treatment option for recurrent nasal polyps. It is a clinically proven treatment for patients suffering from nose, throat, and ear conditions.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027